R&D and Innovation
Product Name
Preclinical
Clinical Application
Phase I Clinical
Phase II Clinical
Phase III Clinical
Marketing Application
Liraglutide Injection
Insulin Degludec Injection
Semaglutide Injection（T2D）
Semaglutide Injection（Overweight / Obesity）
Insulin Degludec and Aspart Injection
CA111
